Clinical Trial Update: The STem Cell Application Researches and Trials In NeuroloGy-2 (STARTING-2) Study [Phase 3]

View source ↗

Summary

The STARTING-2 Phase 3 stem cell trial for ischemic stroke is undergoing an update, sponsored by Samsung Medical Center.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Snippet

Sponsor: Samsung Medical Center | Conditions: Stroke, Ischemic | Phase 3 | Status: UNKNOWN